Literature DB >> 15688968

Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection.

Darius M Moshfeghi1, Peter K Kaiser, Sophie J Bakri, Richard S Kaiser, Raj K Maturi, Jonathan E Sears, Ingrid U Scott, Jonathan Belmont, Paul M Beer, Hugo Quiroz-Mercado, William F Mieler.   

Abstract

BACKGROUND AND
OBJECTIVE: To report acute postoperative, presumed sterile endophthalmitis following intravitreal injection of triamcinolone acetonide (IVTA). PATIENTS AND METHODS: Retrospective, interventional, multicenter study of patients with acute sterile endophthalmitis following IVTA injection.
RESULTS: A total of 922 IVTA injections were performed. Eight eyes of 8 patients with presumed sterile endophthalmitis were identified. The incidence of endophthalmitis was 0.87% (95% confidence interval, 0.38% to 1.70%). Median time to presentation was 1.5 days (range, 1 to 7 days). Median presenting visual acuity was 20/563 (range, 20/80 to light perception). Initial treatment included vitreous tap and injection of antibiotics (n = 4), pars plana vitrectomy and injection of intravitreal antibiotics (n = 2), or systemic treatment alone with oral levofloxacin (n = 2). Six of 6 intraocular cultures were sterile. Median follow-up was 5.9 months (range, 4 to 9 months) with a median visual acuity at last follow-up of 20/75 (range, 20/40 to counting fingers).
CONCLUSIONS: Acute presumed sterile endophthalmitis following IVTA injection presents early in the postoperative period. Visual outcomes are generally good.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688968

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  23 in total

1.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Javier A Montero; Jose M Ruiz-Moreno
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

2.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

3.  Severe bacterial endophthalmitis: towards improving clinical outcomes.

Authors:  Billy D Novosad; Michelle C Callegan
Journal:  Expert Rev Ophthalmol       Date:  2010-10

4.  Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.

Authors:  Sandra Suarez; Gary W McCollum; Colin A Bretz; Rong Yang; Megan E Capozzi; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

Review 5.  Uveitis: advances in understanding of pathogenesis and treatment.

Authors:  Russell W Read
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

6.  Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection.

Authors:  Seong Joon Ahn; Tae Wan Kim; Jeeyun Ahn; Jang Won Huh; Hyeong Gon Yu; Hum Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-22       Impact factor: 3.117

7.  Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.

Authors:  Shabari S Bhatt; Kimberly E Stepien; Komal Joshi
Journal:  Retina       Date:  2011-11       Impact factor: 4.256

8.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Authors: 
Journal:  Ophthalmology       Date:  2008-07-26       Impact factor: 12.079

9.  Intravitreal triamcinolone for intraocular inflammation and associated macular edema.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  [Endophthalmitis after repeated bevacizumab injections].

Authors:  K B Schaal; A E Höh; A Scheuerle; S Dithmar
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.